Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Operating Leases: 2020-2023

Historic Operating Leases for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to $460,000.

  • SELLAS Life Sciences Group's Operating Leases fell 10.56% to $576,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $576,000, marking a year-over-year decrease of 10.56%. This contributed to the annual value of $460,000 for FY2023, which is 19.72% down from last year.
  • SELLAS Life Sciences Group's Operating Leases amounted to $460,000 in FY2023, which was down 19.72% from $573,000 recorded in FY2022.
  • SELLAS Life Sciences Group's Operating Leases' 5-year high stood at $825,000 during FY2020, with a 5-year trough of $460,000 in FY2023.
  • Its 3-year average for Operating Leases is $547,667, with a median of $573,000 in 2022.
  • Data for SELLAS Life Sciences Group's Operating Leases shows a maximum YoY declined of 26.06% (in 2021) over the last 5 years.
  • SELLAS Life Sciences Group's Operating Leases (Yearly) stood at $825,000 in 2020, then dropped by 26.06% to $610,000 in 2021, then dropped by 6.07% to $573,000 in 2022, then dropped by 19.72% to $460,000 in 2023.